Yonhap Infomax NewsApr 8, 2025
GC 녹십자 receives MFDS approval for locally developed anthrax vaccine, enhancing national biodefense capabilities and vaccine sovereignty
#YonhapInfomax #GC녹십자 #AnthraxVaccine #MFDS #Varithrax #BiodefenseCapabilities #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=57751
GC녹십자 Succeeds in Localizing Anthrax Vaccine - MFDS Approval Granted

GC 녹십자 receives MFDS approval for locally developed anthrax vaccine, enhancing national biodefense capabilities and vaccine sovereignty

Yonhap Infomax